Cholestyramine therapy and intestinal obstruction in infants.
Two infants are reported who developed partial intestinal obstruction following cholestyramine therapy for intrahepatic cholestatic syndromes. The hazards of this potential side effect of cholestyramine therapy are emphasized.
D002779:Cholestasis / Q000188:drug therapy; D002792:Cholestyramine Resin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007415:Intestinal Obstruction / Q000139:chemically induced*
D002792:Cholestyramine Resin